1. Home
  2. BORR vs CTY Comparison

BORR vs CTY Comparison

Compare BORR & CTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$3.44

Market Cap

995.8M

Sector

Energy

ML Signal

N/A

CTY

City Therapeutics Inc. Common Stock

N/A

Current Price

$17.55

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BORR
CTY
Founded
2016
2023
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
995.8M
1.0B
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
BORR
CTY
Price
$3.44
$17.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$4.93
★ $37.33
AVG Volume (30 Days)
★ 8.5M
250.4K
Earning Date
11-18-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$62.96
Revenue Next Year
$17.14
$7.47
P/E Ratio
$20.64
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$15.81
52 Week High
$6.66
$22.65

Technical Indicators

Market Signals
Indicator
BORR
CTY
Relative Strength Index (RSI) 43.43 41.04
Support Level $3.10 $16.12
Resistance Level $4.64 $21.98
Average True Range (ATR) 0.20 2.35
MACD -0.00 -0.15
Stochastic Oscillator 31.90 25.44

Price Performance

Historical Comparison
BORR
CTY

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About CTY City Therapeutics Inc. Common Stock

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

Share on Social Networks: